Considerable evidence has shown that lncRNA XIST is dysregulated in a variety of human cancers, and this dysfunctional expression is associated with the clinicopathologic characteristics in cancer patients, including overall survival (OS), tumor stage, lymph node metastasis (LNM), and distant metastasis (DM) [13–15]. The gene discussed is XIST; the disease is cancer.